(Q41921823)

14 October 2017

title

Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications (English)

1 reference

14 October 2017

1 reference

1 reference

Gail Kerr

1

1 reference

14 October 2017

Mireille Aujero

2

1 reference

14 October 2017

John Richards

3

1 reference

14 October 2017

Harlan Sayles

4

1 reference

14 October 2017

Lisa Davis

5

1 reference

14 October 2017

Grant Cannon

6

1 reference

14 October 2017

Liron Caplan

7

1 reference

14 October 2017

Kaleb Michaud

8

1 reference

14 October 2017

Ted Mikuls

9

1 reference

14 October 2017

publication date

1 November 2014

1 reference

Arthritis Care and Research

14 October 2017

published in

1 reference

14 October 2017

volume

66

1 reference

14 October 2017

issue

11

1 reference

14 October 2017

page(s)

1619-1626

1 reference

Cardiovascular morbidity and mortality in rheumatoid arthritis

14 October 2017

cites work

1 reference

Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management

21 January 2018

1 reference

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

21 January 2018

1 reference

Atherosclerosis: the new view

21 January 2018

1 reference

Cardiovascular outcomes in male veterans with rheumatoid arthritis.

21 January 2018

1 reference

Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry

21 January 2018

1 reference

Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis

21 January 2018

1 reference

Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells

21 January 2018

1 reference

Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy

21 January 2018

1 reference

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

21 January 2018

1 reference

Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies

21 January 2018

1 reference

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

21 January 2018

1 reference

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

21 January 2018

1 reference

Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients

21 January 2018

1 reference

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

Inhibition of hepatic cholesterol biosynthesis by chloroquine

21 January 2018

1 reference

Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006.

21 January 2018

1 reference

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.

21 January 2018

1 reference

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action

21 January 2018

1 reference

How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial

21 January 2018

1 reference

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

21 January 2018

1 reference

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

Hydroxychloroquine: from malaria to autoimmunity

21 January 2018

1 reference

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

21 January 2018

1 reference

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

21 January 2018

1 reference

Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection

21 January 2018

1 reference

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.22341

1 reference

14 October 2017

1 reference